Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Non-Small-Cell Lung

Explore clinical trials studying Carcinoma, Non-Small-Cell Lung. Study availability and eligibility vary by location and protocol.

440 public trials 56 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Non-Small-Cell Lung trial results

Completed

Study to Evaluate the Safety of Pembrolizumab in Participants With Unresectable or Metastatic Melanoma or Non-small Cell Lung Cancer in India (MK-3475-593/KEYNOTE-593)

NCT03715205

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +18 more
Locations
  • Nizam's Institute of Medical Sciences ( Site 0011) Hyderabad, Andhra Pradesh, India
  • Artemis Health Institute ( Site 0007) Gurgaon, Haryana, India
  • Tata Memorial Hospital [M] ( Site 0005) Mumbai, Maharashtra, India
  • Kokilaben Ben Dhirubhai Ambani Hosp & Med Res Inst. ( Site 0001) Mumbai, Maharashtra, India
View Trial Details
Completed

The Watch the Spot Trial

NCT02623712

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations
  • Kaiser Permanente Southern California Pasadena, California, United States
View Trial Details
Completed

Drug-Drug Interaction Study of TAK-788 and Midazolam in Participants With Advanced Non-small Cell Lung Cancer (NSCLC)

NCT04051827

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations
  • Royal North Shore Hospital St Leonards, New South Wales, Australia
  • Flinders Medical Centre Bedford Park, South Australia, Australia
  • Peninsula and Southeast Oncology Frankston, Victoria, Australia
  • Nucleus Network Melbourne, Victoria, Australia
View Trial Details
Completed

Pharmaco-economic Study of a Second Line Treatment in Advanced Non Small Cell Lung Cancer

NCT00284778

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations
  • Service de Pneumologie, CHU Angers Angers, France
  • Service de pneumologie; Centre Hospitalier d'Annecy Annecy, France
  • Service de Pneumologie; Centre Hospitalier Beauvais, France
  • Service de Pneumologie ; Centre hospitalier Charleville-Mézières, France
View all 18 locations
View Trial Details
Completed

Xentuzumab (BI 836845) Plus Afatinib in Patients With Epidermal Growth Factor Receptor (EGFR) Mutant Non-small Cell Lung Cancer (NSCLC)

NCT02191891

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations
  • National Hospital Organization Kyushu Cancer Center Fukuoka, Fukuoka, Japan
  • National Cancer Centre Singapore Singapore
  • Chungbuk National University Hospital Cheongju-si, South Korea
  • Severance Hospital Seoul, South Korea
View Trial Details

Related conditions